Biointron is excited to announce our participation in the 16th World Bispecific Summit 2025, taking place in Boston, MA, in September 2025. This premier event is dedicated to the development and advancement of bispecific antibodies. This summit serves as a key platform for industry leaders, researchers, and innovators to explore the latest breakthroughs in bispecific antibody engineering, therapeutic applications, and clinical advancements.
Bispecific antibodies are revolutionizing therapeutic development by enabling precise targeting of multiple disease pathways. Their potential spans oncology, immunotherapy, and beyond, offering new hope for treating complex and challenging diseases. As a leader in antibody discovery and engineering, Biointron is committed to pioneering innovative bispecific solutions that enhance efficacy, specificity, and manufacturability.
At the 16th World Bispecific Summit 2025, we look forward to engaging in in-depth discussions on the latest trends in bispecific antibody formats, addressing challenges in stability and production, and exploring novel applications in drug development. Our team will be available to connect with industry professionals, share insights from our latest research, and discuss potential collaborations to drive the future of bispecific antibody therapeutics.
For more details about the event, please visit the 16th World Bispecific Summit 2025 website [https://bispecific.com/]
Time: September, 2025
Location: Boston, MA
Booth: #TBD
